Literature DB >> 12423858

Pregnancy after classic cesarean delivery.

Suneet P Chauhan1, Everett F Magann, Christopher D Wiggs, P Scott Barrilleaux, James N Martin.   

Abstract

OBJECTIVE: To describe maternal and perinatal outcomes after a prior classic cesarean delivery.
METHODS: A retrospective review was performed including all patients from 1990-2000 whose most recent pregnancy was preceded by classic cesarean delivery.
RESULTS: During the 11-year period, there were 37,863 deliveries and 157 patients (0.4%) underwent classic cesarean operations. In the next pregnancy, one case of uterine rupture (0.6%, 95% confidence interval 0.1, 3.5) occurred at 29 weeks without preterm labor and resulted in fetal death. The prevalence of asymptomatic dehiscence was 9% (95% confidence interval 5, 15). There was no significant difference between patients with uterine dehiscence (n = 15) and patients with intact uteri (n = 141) with regard to maternal demographics, duration of labor, cervical dilatation at time of surgery, transfusion of packed red cells, bowel injury, postpartum endometritis, wound breakdown, thrombophlebitis, or umbilical arterial pH less than 7.00 (P >.05). Duration of labor, cervical dilatation, and gestational age at repeat cesarean delivery were poor predictors for uterine rupture or dehiscence.
CONCLUSION: Among patients with prior classic cesarean delivery, uterine rupture and dehiscence are neither predictable nor preventable. One in four patients will experience some form of maternal morbidity. Uterine rupture, although infrequent, can be fatal to the fetus. Uterine dehiscence, however, does not increase neonatal or peripartum maternal morbidity.

Entities:  

Mesh:

Year:  2002        PMID: 12423858     DOI: 10.1016/s0029-7844(02)02239-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Subsequent pregnancy outcomes after open maternal-fetal surgery for myelomeningocele.

Authors:  William H Goodnight; Ozan Bahtiyar; Kelly A Bennett; Stephen P Emery; J B Lillegard; Allan Fisher; Ruth Goldstein; Jillian Jatres; Foong-Yen Lim; Laurence McCullough; Ueli Moehrlen; Julie S Moldenhauer; Anita J Moon-Grady; Rodrigo Ruano; Daniel W Skupski; Elizabeth Thom; Marjorie C Treadwell; KuoJen Tsao; Amy J Wagner; Lindsay N Waqar; Michael Zaretsky
Journal:  Am J Obstet Gynecol       Date:  2019-03-15       Impact factor: 8.661

2.  Amniocentesis for fetal lung maturity: will it become obsolete?

Authors:  Stephen Varner; Craig Sherman; David Lewis; Sheri Owens; Frankie Bodie; C Eric McCathran; Nicolette Holliday
Journal:  Rev Obstet Gynecol       Date:  2013

3.  Counselling and management for anticipated extremely preterm birth.

Authors:  Brigitte Lemyre; Gregory Moore
Journal:  Paediatr Child Health       Date:  2017-08-11       Impact factor: 2.253

Review 4.  Shared decision making for infants born at the threshold of viability: a prognosis-based guideline.

Authors:  B Lemyre; T Daboval; S Dunn; M Kekewich; G Jones; D Wang; M Mason-Ward; G P Moore
Journal:  J Perinatol       Date:  2016-05-12       Impact factor: 2.521

Review 5.  Timing of indicated late-preterm and early-term birth.

Authors:  Catherine Y Spong; Brian M Mercer; Mary D'Alton; Sarah Kilpatrick; Sean Blackwell; George Saade
Journal:  Obstet Gynecol       Date:  2011-08       Impact factor: 7.623

6.  Silent Spontaneous Uterine Rupture at 36 Weeks of Gestation.

Authors:  J Y Woo; L Tate; S Roth; A C Eke
Journal:  Case Rep Obstet Gynecol       Date:  2015-08-19

7.  Vaginal repaired cesarean section diverticulum is beneficial in women with two prior cesarean sections.

Authors:  Yizhi Wang; Jiarui Li; Husheng Wang; Xipeng Wang
Journal:  BMC Womens Health       Date:  2020-04-23       Impact factor: 2.809

8.  Efficacy of Combined Laparoscopic and Hysteroscopic Repair of Post-Cesarean Section Uterine Diverticulum: A Retrospective Analysis.

Authors:  Cuilan Li; Shiyan Tang; Xingcheng Gao; Wanping Lin; Dong Han; Jinguo Zhai; Xuetang Mo; Lee Jaden Gil Yu Kang Zhou
Journal:  Biomed Res Int       Date:  2016-03-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.